Published by
@ShahidNShah
@ShahidNShah
When it comes to coronavirus, we have flexible solutions for your testing and research needs
In response to the global outbreak of the novel coronavirus disease (COVID-19), Luminex has developed multiple solutions to enhance our offerings to automate and facilitate the detection of SARS-CoV-2 and COVID-19 research.
Molecular SARS-CoV-2 Testing Solutions - NxTAG® CoV Extended Panel:
As a high-throughput, more comprehensive option for high-complexity labs, we have developed the NxTAG® CoV Extended Panel, which can detect SARS-CoV-2. We have received Emergency Use Authorization (EUA) from the US FDA and Medical Device Authorization for Importation or Sale for Health Canada.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm